New active agents. the composition of commercial pharmaceutical specialties in 2001
Bernard, M.
Journal de Pharmacie de Belgique 57(1): 1-13
2002
ISSN/ISBN: 0047-2166 PMID: 11913094 Document Number: 542925
Document emailed within 1 workday
Related Documents
Buitrago, F.; Nieto-Hernández, T. 1994: Errors in the composition of pharmaceutical specialties in the vade mecum Atencion Primaria 13(2): 89-90Desideri, D. 1984: Method for the determination of prices of pharmaceutical specialties as an instrument for improving investments in research Bollettino Chimico Farmaceutico 123(11): 493-504
Moncrieff, J.; Thomas, P. 2002: The pharmaceutical industry and disease mongering. Psychiatry should not accept so much commercial sponsorship Bmj 325(7357): 216; Author Reply 216
Stone, R.A.; Graham, S.; Kerr, G.B. 1974: Commercial distribution of contraceptives in Afghanistan: actual and potential use of the pharmaceutical marketing system Studies in Family Planning 5(3): 83-89
Allwood, M.C. 1978: Antimicrobial agents as preservatives in pharmaceutical and cosmetic products. Antimicrobial agents in single- and multi-dose injections Journal of Applied Bacteriology 44(3): S8-S17
Peterson, D.W.; Lilyblade, A.; Clifford, C.K.; Ernst, R.; Clifford, A.J.; Dunn, P. 1978: Composition of and cholesterol in Araucana and commercial eggs Journal of the American Dietetic Association 72(1): 45-47
Szcześniak, M.; Pluta, J. 2009: The effect of the composition of hydrophilic base on pharmaceutical availability of prednisolone Polimery W Medycynie 39(4): 45-49
Voĭtenko, G.A. 1990: The regulation of the composition of commercial forms of pesticides and the principles for evaluating their toxicity and hazards Gigiena i Sanitariia 10: 40-42
Geiger, C.M.; Sorenson, B.; Whaley, P. 2015: Stability Assessment of 10 Active Pharmaceutical Ingredients Compounded in SyrSpend SF International Journal of Pharmaceutical Compounding 19(5): 420-427
Ciminera, J.L.; Heyse, J.F.; Mantel, N.; Pitot, P.C. 1984: Design of cancer assays for pharmaceutical agents Journal of the National Cancer Institute 72(6): 1212
Talbert, R.L.; Gal, P.; Dukes, G.E.; Miller, W.A.; Porter, W.C.; Rush, D.R.; Schneider, P.; Vlasses, P.H.; Zarowitz, B.J. 1992: Pharmacotherapy specialty certification examination. II. Blueprint to examination. The Board of Pharmaceutical Specialties' Specialty Council on Pharmacotherapy PharmacoTherapy 12(6): 484-490
Puranik, S.B.; Pawar, V.R.; Lalitha, N.; Pai, P.N.S.; Rao, G.K. 2009: Residual solvent analysis in hydrochloride salts of active pharmaceutical ingredients Pakistan Journal of Pharmaceutical Sciences 22(4): 410-414
Hagemann, P. 1978: In vitro active ingredient liberation of five commercial prednisolone preparations in tablet form Pharmaceutica Acta Helvetiae 53(5): 133-135
Huang, L.S. 1983: Progress in the pharmaceutical chemistry of antimalarial agents during the last 2 decades Yao Xue Xue Bao 18(7): 553-560
De Leenheer, A.; Heyndrickx, A. 1971: Identification of phenothiazine derivatives and analogs by x-ray diffraction. II. Active substances in pharmaceutical formulations Journal - Association of Official Analytical Chemists 54(3): 633-642
Fortunak, J.M.; de Souza, R.O.M.A.; Kulkarni, A.A.; King, C.L.; Ellison, T.; Miranda, L.S.M. 2014: Active pharmaceutical ingredients for antiretroviral treatment in low- and middle-income countries: a survey Antiviral Therapy 19(Suppl 3): 15-29
Grigorovich, N.A.; Balagovskaia, Z.M. 1970: Comparative study of the action of blastomogenic agents on the genetic apparatus of animal cells. I. Effect of different types of blastomogenic agents on the DNA nucleotide composition of cells sensitive to blastomogens Tsitologiia 12(11): 1433-1438
Sklenář, Z.ěk.; Horáčková, K.ři.; Bakhouche, H. 2014: Active pharmaceutical ingredients available as substances for extemporaneous preparation in veterinary medicine in the Czech Republic Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 63(2): 71-74
Pinheiro, E.D.S.; Antunes, O.A.C.; Fortunak, J.M.D. 2008: A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations Antiviral Research 79(3): 143-165
Fürst, W.; Becher, M. 1990: Pharmaceutical and biopharmaceutical evaluation of acetylaminonitropopoxybenzolum (Falimint). 10. Biotransformation of the active substance in chick embryo and in in vitro systems Die Pharmazie 45(7): 534-535